EUVIMED · CrossrefZeitschrift
Molecular Therapy
ISSN 1525-0016 · Elsevier BV
Neueste Artikel
LILRB1 as a novel therapeutic target for CAR-T therapy in diffuse large B cell lymphoma
Lineage-specific pulmonary transcriptome landscape of coronavirus infection unveils universal immunotherapy for viral pneumonia
Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease
Integrin α7 defines a profibrotic adipose stromal population targeted for nanoparticle PAI-1 gene silencing in obesity
The DreAM-plus integrative RNA switch enhances transient AAV expression and reduces side effects of gene editing
Lipid nanoparticle-based multi-scale systemic immune programming for cancer therapy
Viral gene replication enhances AAV vector quality and reduces manufacturing costs
DC vaccine loaded with Bacteroides fragilis elicits functional cross-reactivity and enhances anti-PD-1 immunotherapy
A complement C5-targeted GalNAc-conjugated siRNA with sustained efficacy in a non-human primate model of IgA nephropathy
Leveraging host-cell modulators of adeno-associated vector transduction to tailor viral biodistribution
Intranasal delivery of a vasoactive intestinal peptide-based circRNA vaccine induces systemic and mucosal immunity against RSV in mice
Pan-cancer oncolytic virotherapy through disruption of tumor cell mitochondrial dynamics
ACC1 inhibition enhances BCG-induced trained immunity by reprogramming acetyl-CoA metabolism
Targeting EZH2 and EGFR therapeutic vulnerabilities of TNBC with a single chemical entity confers preclinical treatment advantage
C-terminal CD28 phosphorylation, pY218, modulates IL-2 secretion and therapeutic effect of CAR-T cells
Discovery of synthetic TBK1 activator inducing type I interferon-mediated antiviral and antitumor immunity
Healing helminths: A systematic review of the anti-inflammatory and disease-modifying potential of helminth-derived proteins
MITF-SCD1 lipid metabolic axis prevents ouabain-induced spiral ganglion neuron ferroptosis and hearing loss
Targeting of the oncogenic fusion EWSR1-FLI1 in Ewing sarcoma by CRISPR/dCas9 silencers
Rational and computation-assisted engineering of a compact and efficient CRISPR-Cas12f genome editor
BRD4 inhibition mitigates acute and chronic corneal injury following topical nitrogen mustard exposure
Protein-based masks to unlock conditional activation of therapeutics
Optimization of AsCas12f1-mediated long-term gene repression
Ammonium tetrathiomolybdate improves auditory and vestibular function after gentamicin exposure via the NRF2-GPX4 axis
Retraction Notice to: Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222
Development of CRISPR_SCD001, an autologous hematopoietic stem cell gene therapy for sickle cell disease
Targeted epigenetic reactivation strategies as new treatments for Prader-Willi syndrome: Achievements and challenges
p38 MAPK inhibition safeguards genome integrity during gene editing of hematopoietic stem and progenitor cells
Pre-clinical validation of AAV gene therapy for KCNV2 retinopathy improves visual function and expression in mouse and patient models
Breakthroughs in cell and gene therapy: Innovations in therapeutic modalities for the CNS, targeted delivery, translation, and CMC
EUVIMED